Arrhythmia Research Technology Announces New Stock Buy Back Program
06 Octubre 2008 - 8:27AM
Marketwired
Arrhythmia Research Technology, Inc. (the "Company") (AMEX: HRT)
announced that its Board of Directors has authorized the repurchase
of up to $650,000 of the Company's common stock from time to time,
subject to prevailing conditions and price levels.
Any repurchases will be made in the open market, through
negotiated or block transactions, using the Company's existing
general corporate funds. The repurchase program replaces a previous
inactive plan adopted in June of 2003 and may be modified,
suspended or discontinued at any time.
As of September 30, 2008, the Company had 2,711,680 shares of
common stock outstanding.
The Company, through Micron, manufactures silver plated and
non-silver plated conductive resin sensors and distributes metal
snaps used in the manufacture of disposable ECG, EEG, EMS and TENS
electrodes. Micron's NEM division manufactures custom injection
molded products for medical, electronic, industrial and consumer
applications. Micron's MIT division provides end-to-end product
life cycle management through a comprehensive portfolio of
value-added services such as design, engineering, prototyping,
manufacturing, machining, assembly and packaging. Micron's
Leominster Tool division provides high end mold design and
manufacturing for the injection molding industry. The Company's
products also include proprietary signal-averaging
electrocardiography (SAECG) software used in the detection of
potentially lethal heart arrhythmias.
For more information please visit our websites:
http://www.arthrt.com
http://www.newenglandmolders.com
http://www.leominstertool.com
http://www.micronproducts.com
http://www.micronintegrated.com
Forward-looking statements made herein are based on current
expectations of the Company that involve a number of risks and
uncertainties and should not be considered as guarantees of future
performance. The factors that could cause actual results to differ
materially include: interruptions or cancellation of existing
contracts, impact of competitive products and pricing, product
demand and market acceptance, risks, the presence of competitors
with greater financial resources than the Company, product
development and commercialization risks, changing economic
conditions in developing countries, and an inability to arrange
additional debt or equity financing. More information about factors
that potentially could affect the Company's financial results is
included in the Company's filings with the Securities and Exchange
Commission, including its Annual Report on Form 10-K for the year
ended December 31, 2007.
Contact: David A. Garrison (978) 345-5000 Website:
http://www.arthrt.com
Micron Solutions (AMEX:MICR)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Micron Solutions (AMEX:MICR)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024